Reverb Therapeutics, a biotech company leveraging the natural immune system to treat life-threatening diseases, has raised $17 million in financing. The funding round was led by founding investor Amplitude Ventures and included participation from the Myeloma Investment Fund, KdT Ventures, Finchley Healthcare Ventures, Seido Capital, and InBC Investment Corp. Reverb’s Amplify•R™ platform utilizes bispecific antibody […]